Hepatocellular carcinoma lesion characterization: Single-institution clinical performance review of multiphase gadolinium-enhanced MR imaging - Comparison to prior same-center results after MR systems improvements

Radiology

Volumn 261, Issue 3, 2011, Pages 824-833

  Becker Weidman, David J S ^a   Kalb, Bobby ^a,c   Sharma, Puneet ^a,c   Kitajima, Hiroumi D ^a,c   Lurie, Christina R ^a,c   Chen, Zhengjia ^b   Spivey, James R ^a   Knechtle, Stuart J ^a   Hanish, Steven I ^a   Adsay, N Volkan ^a   Farris III, Alton B ^a   Martin, Diego R ^a,c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOBENATE DIMEGLUMINE;

ADULT; AGED; ARTICLE; CHEMOEMBOLIZATION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; EXPLANT; FALSE POSITIVE RESULT; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TUMOR LOCALIZATION; TUMOR VOLUME;

CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; FEMALE; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MAGNETIC RESONANCE IMAGING; MALE; MEGLUMINE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 81555218163     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.11110157     Document Type: Article

References (37)

1. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999;340(10):745-750. (Pubitemid 29114292)
2. Kumar M, Kumar R, Hissar SS, et al. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India. J Gastroenterol Hepatol 2007;22(7):1104-1111. (Pubitemid 47019860)
3. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334(11):693-699. (Pubitemid 26079803)
4. United Network for Organ Sharing. http:// www.unos.org/. Accessed August 1, 2010.
5. de Lédinghen V, Laharie D, Lecesne R, et al. Detection of nodules in liver cirrhosis: spiral computed tomography or magnetic resonance imaging? a prospective study of 88 nodules in 34 patients. Eur J Gastroenterol Hepatol 2002;14(2):159-165. (Pubitemid 34163995)
6. Ayyappan AP, Jhaveri KS. CT and MRI of hepatocellular carcinoma: an update. Expert Rev Anticancer Ther 2010;10(4):507-519.
7. Gomaa AI, Khan SA, Leen EL, Waked I, Taylor-Robinson SD. Diagnosis of hepatocellular carcinoma. World J Gastroenterol 2009;15(11):1301-1314.
8. Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001;33(6):1394-1403. (Pubitemid 32496976)
9. Semelka RC, Martin DR, Balci C, Lance T. Focal liver lesions: comparison of dual-phase CT and multisequence multiplanar MR imaging including dynamic gadolinium enhancement. J Magn Reson Imaging 2001;13(3):397-401. (Pubitemid 32173407)
10. Lauenstein TC, Salman K, Morreira R, et al. Gadolinium-enhanced MRI for tumor surveillance before liver transplantation: center-based experience. AJR Am J Roentgenol 2007;189(3):663-670. (Pubitemid 47328550)
11. Krinsky GA, Lee VS, Theise ND, et al. Transplantation for hepatocellular carcinoma and cirrhosis: sensitivity of magnetic resonance imaging. Liver Transpl 2002;8(12):1156-1164. (Pubitemid 35469878)
12. Bruix J, Sherman M;Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 2005;42(5):1208-1236.
13. Willatt JM, Hussain HK, Adusumilli S, Marrero JA. MR imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies. Radiology 2008;247(2):311-330.
14. Lauenstein TC, Sharma P, Hughes T, Heberlein K, Tudorascu D, Martin DR. Evaluation of optimized inversion-recovery fat-suppression techniques for T2-weighted abdominal MR imaging. J Magn Reson Imaging 2008;27(6):1448-1454. (Pubitemid 351770702)
15. Udayasankar UK, Martin D, Lauenstein T, et al. Role of spectral presaturation attenuated inversion-recovery fat-suppressed T2- weighted MR imaging in active inflammatory bowel disease. J Magn Reson Imaging 2008;28(5):1133-1140.
16. Martin DR, Krishnamoorthy SK, Kalb B, et al. Decreased incidence of NSF in patients on dialysis after changing gadolinium contrast-enhanced MRI protocols. J Magn Reson Imaging 2010;31(2):440-446.
17. Sharma P, Kalb B, Kitajima HD, et al. Optimization of single injection liver arterial phase gadolinium enhanced MRI using bolus track real-time imaging. J Magn Reson Imaging 2011;33(1):110-118.
18. Varotti G, Ramacciato G, Ercolani G, et al. Comparison between the fifth and sixth editions of the AJCC/UICC TNM staging systems for hepatocellular carcinoma: multicentric study on 393 cirrhotic resected patients. Eur J Surg Oncol 2005;31(7):760-767. (Pubitemid 41194654)
19. Sachdev M, Hernandez JL, Sharma P, et al. Liver transplantation in the MELD era: a single-center experience. Dig Dis Sci 2006;51(6):1070-1078. (Pubitemid 44127057)
20. Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 1998;17(8):857-872. (Pubitemid 28185165)
21. Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma: conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001;35(3):421-430. (Pubitemid 32844200)
22. Stigliano R, Burroughs AK. Should we biopsy each liver mass suspicious for HCC before liver transplantation? - no, please don't. J Hepatol 2005;43(4):563-568. (Pubitemid 41253220)
23. Kim SH, Lim HK, Lee WJ, Cho JM, Jang HJ. Needle-tract implantation in hepatocellular carcinoma: frequency and CT findings after biopsy with a 19.5-gauge automated biopsy gun. Abdom Imaging 2000;25(3):246-250. (Pubitemid 30304979)
24. Chang S, Kim SH, Lim HK, et al. Needle tract implantation after percutaneous interventional procedures in hepatocellular carcinomas: lessons learned from a 10-year experience. Korean J Radiol 2008;9(3):268-274.
25. Thampanitchawong P, Piratvisuth T. Liver biopsy: complications and risk factors. World J Gastroenterol 1999;5(4):301-304.
26. Compagnon P, Grandadam S, Lorho R, et al. Liver transplantation for hepatocellular carcinoma without preoperative tumor biopsy. Transplantation 2008;86(8):1068-1076.
27. Perkins JD. Seeding risk following percutaneous approach to hepatocellular carcinoma . Liver Transpl 2007;13(11):1603. (Pubitemid 350168205)
28. Choi SH, Lee JM, Yu NC, et al. Hepatocellular carcinoma in liver transplantation candidates: detection with gadobenate dimeglumine-enhanced MRI. AJR Am J Roentgenol 2008;191(2):529-536.
29. European Society for Organ Transplantation. http://www.esot.org/. Accessed August 4, 2010.
30. Park MJ, Kim YS, Lee WJ, Lim HK, Rhim H, Lee J. Outcomes of follow-up CT for small (5-10-mm) arterially enhancing nodules in the liver and risk factors for developing hepatocellular carcinoma in a surveillance population. Eur Radiol 2010;20(10):2397-2404.
31. Byrnes V, Shi H, Kiryu S, Rofsky NM, Afdhal NH. The clinical outcome of small (<20 mm) arterially enhancing nodules on MRI in the cirrhotic liver. Am J Gastroenterol 2007;102(8):1654-1659. (Pubitemid 47206703)
32. Hussain HK, Chenevert TL, Londy FJ, et al. Hepatic fat fraction: MR imaging for quantitative measurement and display - early experience. Radiology 2005;237(3):1048-1055. (Pubitemid 41636400)
33. Naito K, Ohgoshi Y, Ohkubo M, et al. Optimization of flip angle for 3D-VIBE technique in liver dynamic MRI [in Japanese]. Nihon Hoshasen Gijutsu Gakkai Zasshi 2005; 61(10):1441-1446.
34. Wile GE, Leyendecker JR. Magnetic resonance imaging of the liver: sequence optimization and artifacts. Magn Reson Imaging Clin N Am 2010;18(3):525-547, xi.
35. Yao FY, Xiao L, Bass NM, Kerlan R, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging. Am J Transplant 2007;7(11): 2587-2596. (Pubitemid 47561609)
36. Hofvind S, Skaane P, Vitak B, et al. Influence of review design on percentages of missed interval breast cancers: retrospective study of interval cancers in a population-based screening program. Radiology 2005;237(2):437-443. (Pubitemid 41507877)
37. Quinn SF, Neubauer NM, Sheley RC, Demlow TA, Szumowski J. MR imaging of silicone breast implants: evaluation of prospective and retrospective interpretations and interobserver agreement. J Magn Reson Imaging 1996;6(1):213-218. (Pubitemid 126702467)